In Silico Studies of the Relationship Between Chemical Structure and Drug Induced Phospholipidosis

被引:19
作者
Przybylak, Katarzyna R. [1 ]
Cronin, Mark T. D. [1 ]
机构
[1] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England
关键词
Structure-activity relationship; Phospholipidosis (PLD); Cationic amphiphilic drugs (CADs); SMARTS patterns; CELL-BASED APPROACH; TISSUE DISTRIBUTION; AMPHIPHILIC DRUGS; PLASMA-PROTEIN; HEPG2; CELLS; VITRO; ASSAY; RATS; NEPHROTOXICITY; ESTABLISHMENT;
D O I
10.1002/minf.201000164
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Drug-induced phospholipidosis (PLD) is a side effect of the administration of cationic amphiphilic drugs (CADs). It is desirable to identify and screen compounds with the potential to induce PLD as early as possible in drug development. Recently, a number of in silico methods have been developed to predict PLD. These models are low-cost and high-throughput strategies; however, they produce a high number of false positive predictions. The aim of this study was to assess the predictive performance of existing in silico approaches and to develop new strategies for the rapid identification of the potential PLD-inducers. Studies on 450 chemicals confirmed the high false positive rate of prediction of models based only on log P and pK(a) values. Modification of the methods by incorporating structural information gave moderate improvements in the prediction performance. Therefore, a new strategy, based on molecular fragments captured by SMARTS strings was developed. These structural fragments were able to identify potential PLD-inducers and achieved a high sensitivity of 85%. The results showed that the phospholipidosis is linked directly to the molecular structure of chemical; therefore the SMARTS pattern methodology could be used as a first line of screening of PLD potential during the drug discovery process.
引用
收藏
页码:415 / 429
页数:15
相关论文
共 50 条
  • [1] Screening for the Drug-Phospholipid Interaction: Correlation to Phospholipidosis
    Alakoskela, Juha-Matti
    Vitovic, Pavol
    Kinnunen, Paavo K. J.
    [J]. CHEMMEDCHEM, 2009, 4 (08) : 1224 - 1251
  • [2] Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE
    Bhandari, Neetesh
    Figueroa, David J.
    Lawrence, Jeffrey W.
    Gerhold, David Lee
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (03) : 407 - 419
  • [3] A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development
    Casartelli, A
    Bonato, M
    Cristofori, P
    Crivellente, F
    Dal Negro, G
    Masotto, I
    Mutinelli, C
    Valko, K
    Bonfante, V
    [J]. CELL BIOLOGY AND TOXICOLOGY, 2003, 19 (03) : 161 - 176
  • [4] COTRAN RS, 1994, ROBBINS PATHOLOGIC B, P138
  • [5] Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development
    Fujimura, Hisako
    Dekura, Eriha
    Kurabe, Michie
    Shimazu, Noriko
    Koitabashi, Mieko
    Toriumi, Wataru
    [J]. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2007, 58 (06) : 375 - 382
  • [6] Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes
    Gum, RJ
    Hickman, D
    Fagerland, JA
    Heindel, MA
    Gagne, GD
    Schmidt, JM
    Michaelides, MR
    Davidsen, SK
    Ulrich, RG
    [J]. BIOCHEMICAL PHARMACOLOGY, 2001, 62 (12) : 1661 - 1673
  • [7] Cationic amphiphilic drug-induced phospholipidosis
    Halliwell, WH
    [J]. TOXICOLOGIC PATHOLOGY, 1997, 25 (01) : 53 - 60
  • [8] Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: Role of plasma protein and tissue phosphatidylserine binding
    Hanada, K
    Akimoto, S
    Mitsui, K
    Mihara, K
    Ogata, H
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (08) : 1250 - 1256
  • [9] Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
    Hanumegowda, Umesh M.
    Wenke, Gottfried
    Regueiro-Ren, Alicia
    Yordanova, Roumyana
    Corradi, John P.
    Adams, Stephen P.
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2010, 23 (04) : 749 - 755
  • [10] HUMAN ACCUMULATION POTENTIAL OF XENOBIOTICS - POTENTIAL OF CATAMPHIPHILIC DRUGS TO PROMOTE THEIR ACCUMULATION VIA INDUCING LIPIDOSIS OR MUCOPOLYSACCHARIDOSIS
    HEIN, L
    LULLMANNRAUCH, R
    MOHR, K
    [J]. XENOBIOTICA, 1990, 20 (11) : 1259 - 1267